TickerFactsScreenerDevelopers

Lexaria Bioscience Corp. (LEXX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2009: $2.30M2010: $2.15M2011: $2.66M2012: $2.42M2013: $2.10M2014: $1.72M2015: $772.4K2016: $266.0K2017: $2.77M2018: $2.39M2019: $2.49M2020: $2.48M2021: $13.27M2022: $7.95M2023: $3.04M2024: $8.04M2025: $2.99M$2.99M
2009Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$2.99M-62.8%
2024$8.04M+164.0%
2023$3.04M-61.7%
2022$7.95M-40.1%
2021$13.27M+434.4%
2020$2.48M-0.3%
2019$2.49M+4.3%
2018$2.39M-13.7%
2017$2.77M+940.4%
2016$266.0K-65.6%
2015$772.4K-55.0%
2014$1.72M-18.2%
2013$2.10M-13.3%
2012$2.42M-9.0%
2011$2.66M+23.6%
2010$2.15M-6.3%
2009$2.30M—